Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
Published on: May 31, 2024
Chagas disease: host responses, parasite evasion and vaccine advances
1Tropical medicine, Instituto Colombiano de Medicina Tropical-Universidad CES, Cra. 43A #52 Sur - 99, Medellín 055450, Colombia.
Abstract:
Chagas disease is a parasitic infection caused by Trypanosoma cruzi. Although the host immune response has been extensively studied, important knowledge gaps remain, particularly regarding the complex and multifaceted immune evasion mechanisms employed by the parasite, both at the innate and adaptive levels. In recent years, multiple promising vaccine candidates have been developed, but further evaluation is needed across the different phases of clinical trials. Therefore, the aim of this review is to examine the host immune response to T. cruzi, the parasite's immune evasion strategies and recent advances in vaccine development aimed at controlling infection.
Insights
This review explores the immune response to Chagas disease (caused by Trypanosoma cruzi) and its immune evasion tactics. It also covers recent progress in developing vaccines to control this parasitic infection.
Area of Science:
- Parasitology
- Immunology
- Infectious Diseases
Background:
- Chagas disease is a significant public health concern caused by the parasite Trypanosoma cruzi.
- Understanding the host immune response and parasite immune evasion is crucial for disease control.
- Existing knowledge gaps hinder the development of effective interventions.
Purpose of the Study:
- To review the host immune response to Trypanosoma cruzi.
- To examine the immune evasion strategies utilized by the parasite.
- To discuss recent advancements in Chagas disease vaccine development.
Main Methods:
- Literature review of host-parasite interactions in Chagas disease.
- Analysis of innate and adaptive immune responses.
- Evaluation of current vaccine candidates and clinical trial data.
Main Results:
- The host immune response to T. cruzi is complex and involves both innate and adaptive immunity.
- T. cruzi employs sophisticated mechanisms to evade host immune responses.
- Several vaccine candidates show promise but require further clinical evaluation.
Conclusions:
- Further research into T. cruzi immune evasion is essential.
- Continued clinical trials are necessary to validate vaccine efficacy.
- Integrated strategies combining immunotherapy and vaccination may be key to controlling Chagas disease.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

